Search research articles
Contact Us
Filters
Showing results (31-40 of 459) with videos related to
Page
of 46
Sort By:
Bone Marrow Transplantation
|
August 13, 2020
Delayed neurotoxicity after axicabtagene ciloleucel therapy in relapsed refractory diffuse large B-cell lymphoma
Talha Badar, Bryon D Johnson, Mehdi Hamadani
British Journal of Haematology
|
November 10, 2007
CD4+ CD56+ haematodermic tumour (plasmacytoid dendritic cell neoplasm)
Mehdi Hamadani, Cynthia M Magro, Pierluigi Porcu
JAMA Oncology
|
November 5, 2020
Allogeneic Transplant Conditioning Regimens for Patients With Non-Hodgkin Lymphoma-Reply
Mehdi Hamadani, Carlos Litovich, Kwang Woo Ahn
Clinical Lymphoma, Myeloma & Leukemia
|
October 7, 2021
Epidemiology of Food Insecurity in a Nationally Representative Sample of Lymphoma Patients
Taral Jella, Thomas B Cwalina, Mehdi Hamadani
Blood Advances
|
September 22, 2021
CAR T-cell therapy for secondary CNS DLBCL
Gulrayz Ahmed, Mehdi Hamadani, Nirav N Shah
Cancer Control : Journal of the Moffitt Cancer Center
|
October 7, 2011
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation in adults with acute myeloid leukemia
Mehdi Hamadani, Mohamad Mohty, Mohamed A Kharfan-Dabaja
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
Reply to S. Fuji et al
Mehdi Hamadani, Jeffrey A Vos, Michael D Craig
Blood Advances
|
October 29, 2025
Reply to Gui and Hourigan
Mark J Levis, Mehdi Hamadani, Yi-Bin Chen
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 8, 2020
Eligibility Criteria for Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Abraham S Kanate, Miguel-Angel Perales, Mehdi Hamadani
Expert Review of Hematology
|
May 3, 2014
Hematopoietic stem cell transplantation in older persons: respecting the heterogeneity of age
Laura C Michaelis, Mehdi Hamadani, Parameswaran N Hari
Page
of 46
Search research articles
Search
Showing results (31-40 of 459) with videos related to
Sort By:
Page
of 46
Bone Marrow Transplantation
|
August 13, 2020
Delayed neurotoxicity after axicabtagene ciloleucel therapy in relapsed refractory diffuse large B-cell lymphoma
Talha Badar, Bryon D Johnson, Mehdi Hamadani
British Journal of Haematology
|
November 10, 2007
CD4+ CD56+ haematodermic tumour (plasmacytoid dendritic cell neoplasm)
Mehdi Hamadani, Cynthia M Magro, Pierluigi Porcu
JAMA Oncology
|
November 5, 2020
Allogeneic Transplant Conditioning Regimens for Patients With Non-Hodgkin Lymphoma-Reply
Mehdi Hamadani, Carlos Litovich, Kwang Woo Ahn
Clinical Lymphoma, Myeloma & Leukemia
|
October 7, 2021
Epidemiology of Food Insecurity in a Nationally Representative Sample of Lymphoma Patients
Taral Jella, Thomas B Cwalina, Mehdi Hamadani
Blood Advances
|
September 22, 2021
CAR T-cell therapy for secondary CNS DLBCL
Gulrayz Ahmed, Mehdi Hamadani, Nirav N Shah
Cancer Control : Journal of the Moffitt Cancer Center
|
October 7, 2011
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation in adults with acute myeloid leukemia
Mehdi Hamadani, Mohamad Mohty, Mohamed A Kharfan-Dabaja
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
Reply to S. Fuji et al
Mehdi Hamadani, Jeffrey A Vos, Michael D Craig
Blood Advances
|
October 29, 2025
Reply to Gui and Hourigan
Mark J Levis, Mehdi Hamadani, Yi-Bin Chen
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 8, 2020
Eligibility Criteria for Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Abraham S Kanate, Miguel-Angel Perales, Mehdi Hamadani
Expert Review of Hematology
|
May 3, 2014
Hematopoietic stem cell transplantation in older persons: respecting the heterogeneity of age
Laura C Michaelis, Mehdi Hamadani, Parameswaran N Hari
Page
of 46